Kim Eun Young, Kim Se Hyun, Rhee Sang Jin, Huh Iksoo, Ha Kyooseob, Kim Jayoun, Chang Jae Seung, Yoon Dae Hyun, Park Taesung, Ahn Yong Min
Mental Health Clinic, National Cancer Center, Goyang, Republic of Korea.
Department of Neuropsychiatry, Dongguk University Medical School, Dongguk University International Hospital, Goyang, Republic of Korea.
Psychoneuroendocrinology. 2015 Aug;58:114-9. doi: 10.1016/j.psyneuen.2015.04.016. Epub 2015 Apr 30.
This study assessed the relationship between thyroid-stimulating hormone (TSH) level and risk of depressive symptom in a population with no clinical or laboratory evidence of thyroid dysfunction.
This retrospective cohort study included 13,017 subjects (7913 males and 5104 females), 17-84 years of age, who underwent health examinations at the hospital. Subjects had a Beck Depression Inventory (BDI) total score of ≤9 and fell within the normal range of free T4 levels at baseline. The association between gender-specific serum TSH tertile at baseline and the development of clinically significant depressive symptom (i.e., ≥19 BDI total score) on the follow-up visit was evaluated using the Cox proportional hazards model, with adjustment for demographic and life style factors.
The risk of depressive symptom was increased among subjects with the highest tertile TSH level (adjusted hazard ratio [HR], 2.236; 95% confidence interval [CI], 1.443-3.466; p<0.001) as compared with subjects with the lowest tertile in females, but not in males. Even among patients with normal TSH levels, females in the lowest-normal TSH tertile had a higher risk of depressive symptoms (adjusted HR, 2.279; 95% CI, 1.456-3.567; p<0.001) than did those in the highest tertile. The TSH level as a continuous variable significantly predicted the depressive symptoms in females (adjusted HR, 1.402; 95% CI, 1.002-1.812; p=0.027).
Our finding suggests that suboptimal thyroid function increases vulnerability to the occurrence of depressive symptom and represents a modifiable risk factor for depression in females.
本研究评估了在无甲状腺功能障碍临床或实验室证据的人群中,促甲状腺激素(TSH)水平与抑郁症状风险之间的关系。
这项回顾性队列研究纳入了13017名年龄在17至84岁之间、在医院接受健康检查的受试者(7913名男性和5104名女性)。受试者的贝克抑郁量表(BDI)总分≤9,且基线时游离T4水平在正常范围内。使用Cox比例风险模型评估基线时按性别划分的血清TSH三分位数与随访时临床上显著抑郁症状(即BDI总分≥19)发生之间的关联,并对人口统计学和生活方式因素进行了调整。
与女性中TSH水平最低三分位数的受试者相比,TSH水平最高三分位数的受试者出现抑郁症状的风险增加(调整后的风险比[HR],2.236;95%置信区间[CI],1.443 - 3.466;p<0.001),但在男性中未观察到这种情况。即使在TSH水平正常的患者中,TSH正常水平最低三分位数的女性出现抑郁症状的风险(调整后的HR,2.279;95%CI,1.456 - 3.567;p<0.001)也高于最高三分位数的女性。TSH水平作为连续变量可显著预测女性的抑郁症状(调整后的HR,1.402;95%CI,1.002 - 1.812;p = 0.027)。
我们的研究结果表明,甲状腺功能欠佳会增加出现抑郁症状的易感性,并且是女性抑郁症的一个可改变的风险因素。